British Prime Minister Boris Johnson was moved to the intensive care unit (ICU) of a London hospital, 10 days after being diagnosed with coronavirus disease 2019 (COVID-19). Also Monday, the CDC released a preliminary report about how COVID-19 is affecting children in the United States.
Ten days after being diagnosed with coronavirus disease 2019 (COVID-19), British Prime Minister Boris Johnson was moved to the intensive care unit (ICU) of a London hospital Monday.
According to The Associated Press, he is not on a ventilator. He was admitted to St. Thomas’ Hospital Sunday for what were said to be routine tests.
But his coronavirus symptoms worsened Monday, just a day after he was admitted for what were said to be routine tests.
The New York Times reported that while Foreign Secretary Dominic Raab, who is standing in for Johnson, said the prime minister remains “in charge” of the government, Raab also admitted that he had not spoken to the prime minister since Saturday.
Johnson, 55, went into self-isolation on March 26.
Also Monday:
The CDC released a preliminary report about how COVID-19 is affecting children in the United States. Between February 12 and April 2, the time period covered by the report, there were 3 pediatric deaths. Relatively few children with COVID-19 are hospitalized, and fewer children than adults experience fever, cough, or shortness of breath.
As of April 2, just 1.7% (2572) cases have been reported in patients aged <18 years among the 149,082 US cases of COVID-19; children account for 22% of the US population. As with adult cases, where men are more often affected than women, a majority (57%) of pediatric patients were males.
Among 345 pediatric cases with information on underlying conditions, 80 (23%) had at least 1 underlying condition, the most common being chronic lung disease, such as asthma; cardiovascular disease; and immunosuppression.
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment
August 9th 2025Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure but future research and development are necessary to fully realize its potential in clinical practice.
Read More
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
RSV's Impact on Heart Health Emphasizes Broader Risks, Vaccination Importance for Older Adults
July 23rd 2025Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in older adults, underscoring the need for vaccination in this population regardless of their preexisting health conditions.
Read More
Depemokimab Reduces Exacerbations Regardless of Baseline Asthma Control
July 3rd 2025Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being reviewed by the FDA.
Read More